Hepatitis C virus inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9212168
APP PUB NO 20130115194A1
SERIAL NO

13667197

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides compounds of formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THERAVANCE BIOPHARMA R&D IP LLC901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA USA 94080

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jiang, Lan Foster City, US 104 749
Lepack, Kassandra Calgary, CA 4 40
Long, Daniel D San Francisco, US 118 941
Loo, Mandy San Jose, US 12 58
McKinnell, Robert Murray Millbrae, US 79 604
Ogawa, Gavin San Francisco, US 5 40
Van, Orden Lori Jean San Francisco, US 22 232

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00